310. 先天異常症候群 Congenital anomalies syndrome Clinical trials / Disease details

臨床試験数 : 10 / 薬物数 : 18 - (DrugBank : 10) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 7

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01434745 (ClinicalTrials.gov)	September 2011	7/9/2011	SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation	Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiv ...	Smith-Lemli-Opitz Syndrome	Drug: Simvastatin;Dietary Supplement: Lactose	Oregon Health and Science University	National Heart, Lung, and Blood Institute (NHLBI)	Terminated	1 Year	89 Years	All	1	N/A	United States
2	NCT01110642 (ClinicalTrials.gov)	July 2011	22/4/2010	Novel Treatment for Syndromic Ichthyoses	Open-label, Pilot Study to Assess Cholesterol-Lovastatin Solution in the Treatment of Syndromic Icht ...	Syndromic Ichthyoses;CHILD Syndrome;Smith Lemli Opitz Syndrome;Conradi Syndrome	Drug: Lovastatin	Northwestern University	NULL	Withdrawn	1 Year	N/A	Both	0	Phase 2	United States
3	NCT01356420 (ClinicalTrials.gov)	January 2011	11/5/2011	Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome	Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving CholesterolSupplemen ...	Smith-Lemli-Opitz Syndrome	Dietary Supplement: Cholesterol supplementation	Oregon Health and Science University	NULL	Terminated	N/A	85 Years	All	21	N/A	United States
4	NCT01773278 (ClinicalTrials.gov)	December 2008	3/12/2012	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Smith-Lemli-Opitz Syndrome;Cone-Rod Dystrophy;Hearing Loss	Drug: Antioxidants;Drug: Cholesterol	University of Colorado, Denver	NULL	Recruiting	N/A	65 Years	All	100	Phase 2	United States
5	NCT00114634 (ClinicalTrials.gov)	June 2005	15/6/2005	Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome	Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome	Smith-Lemli-Opitz Syndrome	Dietary Supplement: Egg yolk preparation with cholesterol;Dietary Supplement: Egg substitute, without c ...	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	NULL	Completed	4 Years	17 Years	All	13	Phase 2	United States
6	NCT00272844 (ClinicalTrials.gov)	January 1998	4/1/2006	Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome	Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome	Smith-Lemli-Opitz Syndrome	Drug: crystalline cholesterol oil-based suspension	Boston Children’s Hospital	NULL	Completed	N/A	N/A	All	23	Phase 1/Phase 2	United States

First Previous1Next Last